lobbying_activities: 1960760

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1960760	42b8faaf-f373-4540-b783-daeadc1fdba1	Q1	ALKERMES, INC.	400458235	ALKERMES, INC.	2017	first_quarter	PHA	Public law #114-198, Cures Opioid Funding Implementation Reauthorization of the Prescription Drug User Fee Act (PDUFA)	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Veterans Affairs, Dept of (VA)		920000	0	0	2017-04-19T14:00:47.760000-04:00